全球评估与先天性心脏病相关的非编码变体
Research square
|January 16, 2026
概括
一种新的方法,SNP Bind-n-Seq,有效地测试了成千上万的先天性心脏病 (CHD) 变体对基因调节的影响. 它确定了影响心脏细胞转录因子结合和基因表达的变异.
科学领域:
- 基因组学就是基因组学.
- 分子生物学分子生物学
- 心血管研究研究心血管研究
背景情况:
- 全基因组关联研究 (GWAS) 已经确定了许多与先天性心脏病 (CHD) 相关的非编码变异.
- 这些变异可能通过改变转录因子 (TF) 结合来破坏基因调节,但功能验证具有挑战性.
- 了解这些变异的功能影响对于CHD研究至关重要.
研究的目的:
- 开发和应用一种高通量方法,以功能性地评估数千种与CHD相关的非编码变体.
- 评估心脏转录因子 (NKX2-5,GATA4,TBX5) 对这些变异的等位结合.
- 使用大规模并行报告者测试 (MPRA) 选CHD变异的基因型依赖性调节活性.
主要方法:
- 开发了SNP Bind-n-Seq,用于对3000多种CHD风险变异的高通量评估,用于基TF结合.
- 利用MPRA来评估基因型依赖性基因表达调制的CHD变体.
- 综合生化结合数据与功能报告员测定结果.
主要成果:
- 鉴定了170个变体,其中有基TF与心脏TFNKX2-5,GATA4和TBX5结合.
- 检测到187种可显著调节基因表达的变异.
- 发现了三种高可信度变异,表明基因型依赖的TF结合,转录活性和心脏细胞中的eQTL行为.
结论:
- 该研究介绍了首次对数千种心血管疾病风险变异的高通量生物化学和功能基因组组合评估.
- SNP Bind-n-Seq和MPRA为非编码变体的功能特征提供了一个强大的方法.
- 这项工作提供了对潜在的先天性心脏病的调节机制的关键见解.
更多相关视频
07:34Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
Published on: May 5, 2018
12.2K
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
13.4K
相关概念视频
Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K
Heart Failure IV: Classification and Diagnostic Evaluation
323
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
323
Comparing Copy Number Variations and SNPs
18.6K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.6K
Single Nucleotide Polymorphisms-SNPs
17.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.9K
Mitral Stenosis II: Clinical features and Diagnostic Tests
223
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
223
Cardiomyopathy I: Introduction and Classification
514
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
514
